Cognition-Enhancing, Antipsychotic, and Opioid Medication Use Among Assisted Living and Residential Care Residents in Oregon.

Authors

Sarah Dys, Portland State UniversityFollow
Ozcan Tunalilar, Portland State UniversityFollow
Paula Carder, Portland State UniversityFollow

Published In

Journal of the American Medical Directors Association

Document Type

Citation

Publication Date

1-28-2021

Abstract

Explore community- and resident-level characteristics associated with polypharmacy and use of cognition-enhancing, antipsychotic, and opioid medications among a statewide representative sample of assisted living and residential care (AL/RC) residents.

Rights

© 2020 AMDA - The Society for Post-Acute and Long-Term Care Medicine.

Locate the Document

https://doi.org/10.1016/j.jamda.2020.12.030

DOI

10.1016/j.jamda.2020.12.030

Persistent Identifier

https://archives.pdx.edu/ds/psu/35335

Citation Details

Dys, S., Tunalilar, O., & Carder, P. (2021). Cognition-Enhancing, Antipsychotic, and Opioid Medication Use Among Assisted Living and Residential Care Residents in Oregon. Journal of the American Medical Directors Association, S1525861020310975. https://doi.org/10.1016/j.jamda.2020.12.030